OPINION AND ORDER
Plaintiff Marvel Comics Limited seeks in-junctive relief and damages against defendant, Defiant, for trademark infringement and unfair competition growing out of defendant’s use of the word “Plasm” in the name of a comic book. Plaintiff also requests that this court grant a declaratory judgment holding that when plaintiffs pending United States trademark registration issues, the attachment of plaintiffs statutory rights will relate back to July 13, 1992, the date a trademark application was filed in the United Kingdom. Defendant moves to dismiss under Rule 12(b)(6) of the Federal Rules of Civil Procedure, arguing that plaintiff has no trademark rights to assert in this action and that declaratory relief is unwarranted. For the reasons set forth below, both defendant’s motion to dismiss and plaintiffs request for declaratory judgment are denied.
I.
This dispute concerns use of the words “Plasmer” and “Plasm” by rival comic book *548 publishers. Plaintiff Marvel Comics Limited has filed trademark applications for the word “Plasmer” in both the United States and the United Kingdom (Complt ¶ 24), and has engaged in pre-sale promotional activity for a new “Plasmer” comic book series. (Complt ¶¶ 25-28) Defendant Defiant used the name “Plasm” and then “Warriors of Plasm” to identify its own comic book series. (Complt ¶¶ 29, 35)
Marvel, the largest creator and publisher of comic books in North America (Complt ¶ 9), alleges that it developed “Plasmer” as a new comic book concept prior to August, 1992. 1 In that month, Marvel distributed approximately 1,500 copies of a promotional brochure entitled “A Gathering of Heroes” at a comic book convention in San Diego, California. (Complt ¶ 15) The brochure “unveiled” the “Plasmer” title to the comic book industry. (Complt ¶ 17)
Marvel further alleges that it sold over 13 million comic books in November 1992, all of which contained an announcement informing readers of Marvel’s new “Plasmer” comic book series. (Complt ¶25) The announcement was part of a “widely read” column called “Stan’s Soapbox” written by Stan Lee, Marvel’s founder. Id. In December 1992, a picture of Marvel’s “Plasmer” character appeared in a trade magazine which has a circulation of approximately 20,000 readers. (Complt ¶ 26) In January 1993, a two page “Plasmer” promotion appeared in a Marvel publication which was distributed to approximately 150 industry professionals at a sales conference. (Complt ¶ 27) Finally, Marvel alleges that it has sent to distributors approximately 12,000-13,000 copies of its September 1993 catalog, which contains an advertisement for “Plasmer.” (Complt ¶ 28)
II.
Defendant Defiant argues that the promotional activities undertaken by Marvel did not, as a matter of law, create trademark rights in the word “Plasmer.” (Def.Mem. at 2) Accordingly, Defiant moves for dismissal because Marvel does not have rights to protect in this suit. Id.
To decide defendant’s Rule 12(b)(6) motion, I must take all the allegations in the complaint as true,
Hishon v. King & Spalding,
Although Marvel has yet to finish registering the “Plasmer” trademark or start selling its “Plasmer” comic books, both parties agree that pre-sale use without registration can provide a basis for trademark priority. (Def.Mem. at 14; Pl.Mem. at 1). The issue is whether the particular uses alleged in Marvel’s complaint, if true, are sufficient to confer trademark rights on Marvel.
In
Windows User, Inc. v. Reed Business Publishing Limited,
To recover for a violation of § 43(a) of the Lanham Act, a party need not demonstrate that a mark is registered; it must however, demonstrate that is has a reasonable interest to be protected against false advertising. Such a reasonable interest is established by a showing of an intent to adopt the mark as a trademark and first “bona fide ” use of the mark in commerce.
Id. at 106 (citations omitted).
Here, plaintiff has demonstrated its intent to adopt the trademark “Plasmer” by filing applications for the mark’s registration in the United States and in the United Kingdom. As for sufficient “use in commerce,” the “talismanic test” is whether or not the use was “sufficiently public to identify or distinguish the marked goods in an appropriate segment of the public mind as those of the adopter of the mark.”
Windows User
at
*549
108 (quoting
New England Duplicating Co. v. Mendes,
When all reasonable inferences are drawn in favor of the plaintiff, as they must be for the purposes of deciding a motion to dismiss,
Walker v. New York,
Defendant Defiant argues that the losing parties in
Windows User
and in
Future Domain Corp. v. Trantor Systems Ltd.,
Defiant contends also that commercial use can be established only if the mark is physically attached to the goods to be trademarked. (Def.Mem. at 10) To support this theory, defendant cites the “Trademark Manual of Examining Procedure” (or “TMEP”), issued by the Patent and Trademark Office as a guide for those applying to register a trademark. Because the TMEP disallows the submission of specimens for trademark consideration that are in the form of “pictures ... advertising circulars, brochures, price fists, announcements, publicity releases, [or] listing[s] in catalogs and trade directories,” (Def.Mem. at 11), defendant surmises that commercial use cannot be established using such media. This argument is unpersuasive. The section of the manual cited outlines procedures for submitting specimens in support of applications for trademark registration. That has little to do with commercial use, which is determined as a matter separate from and independent of trademark registration with the Patent and Trademark Office, and is based entirely on association of the mark in the public mind with a particular product, regardless of how that association is achieved.
III.
Plaintiffs complaint seeks a declaratory judgment regarding its pending trademark applications in the United States and in the United Kingdom. Because the applications were filed by Marvel’s wholly owned subsidiary in the United Kingdom, and the application in the United States was filed within six months of the foreign application, plaintiff may be able to obtain a priority fifing date under Section 44(d) of the Lanham Act, 15 U.S.C. § 1126(d). That section provides that upon issuance of the United States registration, the statutory rights of an eligible foreign applicant will relate back to the date of fifing in the applicant’s country of origin. Plaintiff thus requests a declaratory judgment that “when its U.S. registration *550 issues, its statutory priority of use will relate back to the initial United Kingdom filing date of July 13, 1992 and thus give it priority in the name PLASMER.” (Pl.Mem. at 19)
That Defiant’s liability under Section 44(d) of the Lanham Act is contingent upon the issuance of Marvel’s registration “does not necessarily defeat jurisdiction of a declaratory judgment action.”
Associated Indemnity Corp. v. Fairchild Industries Inc.,
* * # * *
For the reasons discussed above, defendant’s motion to dismiss under Rule 12(b)(6) and plaintiffs request for declaratory judgment are denied.
Notes
. "Plasmer” is the name of a “new being with superpowers" who is created "when a female scientist is ‘protoplasmically’ split into two personae, one good and one evil.” (Complt ¶ 18)
